Scientists control living cells using artificial protein switch
Scientists have created the first completely artificial protein switch that can be ‘programmed’ to modify gene expression.
List view / Grid view
Scientists have created the first completely artificial protein switch that can be ‘programmed’ to modify gene expression.
An antibody has been developed to block a protein secreted by the cells surrounding ovarian and pancreatic cancer tumours.
A new study has shown that proteins derived from the oncogene, KRAS, can transfer between colon cancer cells.
The advent of in vitro culturing of neural cells has been central to driving our understanding of the nervous system.
Immune cell isolation and culture are necessary for both basic research aimed at investigating the functions of different immune cell types, and for expanding specific immune cell populations for therapeutic purposes.
A new study may provide the basis for combating malignant leukemia stem cells.
A new study shows that the activity of p38 is important in MSCs, which can localise around blood vessels.
A cellular pathway may reduce side effects and extend immunotherapy duration in patients with the most common form of liver cancer.
A study has revealed the role of a protein which enables human cytomegalovirus to spread, the number one cause of congenital birth defects in the world.
Researchers have discovered that inhibiting the ID1 protein slows the growth of glioblastoma tumours and reduces resistance to chemotherapy.
The so-called 'longevity gene' has been included in animal models, in which it stopped atherosclerosis.
From the world’s flagship neutron science facility, Institut Laue-Langevin (ILL), Matthew Blakeley shares insights into how they are harnessing the power of neutrons to aid their search for new cancer treatments.
A study has shown that deactivating an enzyme linked to ceramides caused obese mice to improve their metabolic health, indicating a drug target.
Researchers haved mapped the crystal structure of a protein to find out how a drug latches onto it.
New research has identified a potential treatment against diabetic eye disease from the RBP3 protein, found in the retina.